Effects of erythropoietin on glucose metabolism

Hormone and Metabolic Research

Volumn 44, Issue 4, 2012, Pages 279-285

  Mikols, E ^a   Cseh, J ^a   Pap, M ^a   Szijrto, I A ^a   Balogh, A ^a   Laczy, B ^a   Bek, V ^a   Fisi, V ^a   Molnr, G A ^a   Mrei, A ^a   Szebernyi, J ^a   Wittmann, I ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

diabetes mellitus type 1; diabetes mellitus type 2; fat cell; insulin

Indexed keywords

CHLORAL HYDRATE; DEOXYGLUCOSE; ERYTHROPOIETIN; GLUCOSE TRANSPORTER 4; INSULIN; PROTEIN KINASE B; STREPTOZOCIN;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL MEMBRANE; CELL STRAIN 3T3; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

3T3 CELLS; ANIMALS; BIOLOGICAL TRANSPORT; DIABETES MELLITUS; DOWN-REGULATION; ERYTHROPOIETIN; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MALE; MICE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 84859422902     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1301901     Document Type: Article

References (30)

1. Morse B S, Stohlman F Jr. Regulation of erythropoiesis. 18. The effect of incristine and erythropoietin on bone marrow. J Clin Invest: 1966; 45 1241 1250
2. Arcasoy M O. The non-haematopoietic biological effects of erythropoietin. Br J Haematol: 2008; 141 14 31 (Pubitemid 351347536)
3. Youssoufian H, Longmore G, Neumann D, Yoshimura A, Lodish H F. Structure, function, and activation of the erythropoietin receptor. Blood: 1993; 81 2223 2236 (Pubitemid 23127056)
4. Wojchowski D M, Sathyanarayana P, Dev A. Erythropoietin receptor response circuits. Curr Opin Hematol: 2010; 17 169 176
5. Fu P, Jiang X, Arcasoy M O. Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathway. Biochem Biophys Res Commun: 2009; 13; 379 696 701
6. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K, Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem: 1996; 239 494 500 (Pubitemid 26246558)
7. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience: 1997; 76 105 116 (Pubitemid 26407940)
8. Lewczuk P, Hasselblatt M, Kamrowski-Kruck H, Heyer A, Unzicker C, Sirn A L, Ehrenreich H. Survival of hippocampal neurons in culture upon hypoxia: effect of erythropoietin. Neuroreport: 2000; 11 3485 3488
9. Nagai A, Nakagawa E, Choi H B. Erythropoietin and erythropoietin receptors in human CNS neurons, astrocytes, microglia, and oligodendrocytes grown in culture. J Neuropathol Exp Neurol: 2001; 60 386 392 (Pubitemid 32274054)
10. Fenjves E S, Ochoa M S, Cabrera O, Mendez A J, Kenyon N S, Inverardi L, Ricordi C. Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. Transplantation: 2003; 75 1356 1360 (Pubitemid 36513048)
11. Hardee M E, Rabbani Z N, Arcasoy M O, Kirkpatrick J P, Vujaskovic Z, Dewhirst M W, Blackwell K L. Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity. Mol Cancer Ther: 2006; 5 356 361
12. Tsai P T, Ohab J J, Kertesz N, Groszer M, Matter C, Gao J, Liu X, Wu H, Carmichael S T. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci: 2006; 26 1269 1274 (Pubitemid 43237059)
13. Sakanaka M, Wen T C, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA: 1998; 95 4635 4640 (Pubitemid 28207965)
14. Lu K Y, Ching L C, Su K H, Yu Y B, Kou Y R, Hsiao S H, Huang Y C, Chen C Y, Cheng L C, Pan C C, Lee T S. Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha. Circulation: 2010; 121 1828 1837
15. Hojman P, Brolin C, Gissel H, Brandt C, Zerahn B, Pedersen B K, Gehl J. Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles. PLoS One: 2009; 12; 4 e5894
16. Allegra V, Mengozzi G, Martimbianco L, Vasile A. Early and late effects of erythropoietin on glucose metabolism in maintenance hemodialysis patients. Am J Nephrol: 1996; 16 304 308 (Pubitemid 26143579)
17. Bianchi R, Buyukakilli B, Brines M, Savino C, Cavaletti G, Oggioni N, Lauria G, Borgna M, Lombardi R, Cimen B, Comelekoglu U, Kanik A, Tataroglu C, Cerami A, Ghezzi P. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA: 1999; 101 823 828 (Pubitemid 38121042)
18. Nakao T, Matsumoto H, Okada T, Han M, Hidaka H, Yoshino M, Shino T, Yamada C, Nagaoka Y. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med: 1998; 37 826 830
19. Brown J N, Kemp D W, Brice K R. Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis. Pharmacotherapy: 2009; 29 468 472
20. Katz O, Stuible M, Golishevski N, Lifshitz L, Tremblay M L, Gassmann M, Mittelman M, Neumann D. Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models. J Endocrinol: 2010; 205 87 95
21. Czech M P, Buxton J M. Insulin action on the internalisation of the GLUT4 glucose transporter in isolated rat adipocytes. J Biol Chem: 1993; 268 9187 9190 (Pubitemid 23145958)
22. Fisher M D, Frost S C. Translocation of GLUT1 does not account for elevated glucose transport in glucose-deprived 3T3-L1 adipocytes. J Biol Chem: 1996; 271 11806 11809 (Pubitemid 26157250)
23. Rigalleau V, Blanchetier V, Aparicio M, Baillet L, Sneed J, Dabadie H, Gin H. Erythropoietin can deteriorate glucose control in uraemic non-insulin-dependent diabetic patients. Diabetes Metab: 1998; 24 62 65 (Pubitemid 28097888)
24. Ng J M, Cooke M, Bhandari S, Atkin S L, Kilpatrick E. The effect of iron and erythropoietin treatment on the HbA1c of patients with diabetes mellitus and chronic kidney disease. Diabetes Care: 2010; 33 2310 2313
25. Richmond T D, Chohan M, Barber D L. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol: 2005; 15 146 155 (Pubitemid 40332537)
26. Burn J, Liu H X, Lauritz J, Eriksson J W. High glucose and insulin in combination cause insulin receptor substrate-1 and -2 depletion and protein kinase B desensitisation in primary cultured rat adipocytes: possible implications for insulin resistance in type 2 diabetes. Eur J Endocrinol: 2003; 148 157 167 (Pubitemid 36176016)
27. Rondinone C M, Wang L M, Lonnroth P, Wesslau C, Pierce J H, Smith U. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA: 1997; 94 4171 4175 (Pubitemid 27180518)
28. Toba H, Sawai N, Morishita M, Murata S, Yoshida M, Nakashima K, Morita Y, Kobara M, Nakata T. Chronic treatment with recombinant human erythropoietin exerts renoprotective effects beyond hematopoiesis in streptozotocin-induced diabetic rat. Eur J Pharmacol: 2009; 612 106 114
29. Rasic-Milutinovic Z, Perunicic-Pekovic G, Cavala A, Gluvic Z, Bokan L, Stankovic S. The effect of recombinant human erythropoietin treatment on insulin resistance and inflammatory markers in non-diabetic patients on maintenance hemodialysis. Hippokratia: 2008; 12 157 161 (Pubitemid 351962100)
30. Cayla J, Lavoie C, Gareau R, Duvallet A. Effects of recombinant erythropoietin (r-HuEPO) on plasma glucose concentration in endurance-trained rats. Acta Physiol Scand: 1999; 166 247 249 (Pubitemid 29389471)